Inventaire - your friends and communities are your best library

Emerging strategies and applications of pharmacogenomics

Published in: Human genomics

Date of publication: November 1, 2004

Language: English

Main subject: pharmacogenetics, genetic variation, biomedical investigative technique, pharmacogenomics, genetics

Bibliographic databases:

Cites articles 78

Date

Title

Authors

June 1, 1973

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
January 9, 1987

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
September 1, 1990

Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency
November 1, 1990

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
May 1, 1991

Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic,Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
September 1, 1995

A comparison of linkage disequilibrium measures for fine-scale mapping
September 7, 1995

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
September 1, 1996

Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study

, , , , , , ,
August 1, 1996

A polymorphic site in the 3' untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity
November 1, 1996

Risch's lambda values for human obesity
July 1, 1997

Genetic and environmental factors in relative body weight and human adiposity

, ,
February 1, 1997

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences
November 1, 1997

Variations on a theme: cataloging human DNA sequence variation
May 1, 1998

Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome

, ,
July 1, 1998

It's raining SNPs, hallelujah?
November 1, 1998

ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans
November 1, 1998

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

,
September 1, 1999

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
October 1, 1999

Pharmacogenomics: translating functional genomics into rational therapeutics
August 1, 1999

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
January 1, 1999

Pharmacogenetics

,
June 1, 1999

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
October 1, 1999

Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers

,
November 1, 2000

Assessment of a genetic contribution to osteoarthritis of the hip: sibling study

, ,
September 1, 2000

Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance
January 1, 2000

CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting,CYP2D6 Genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting
November 1, 2000

The genetic contribution to radiographic hip osteoarthritis in women: results of a classic twin study

, ,
October 2001

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
September 1, 2001

Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy
July 12, 2001

Haplotype variation and linkage disequilibrium in 313 human genes
August 3, 2001

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
June 15, 2001

Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells

Article -

Welcome to inventaire

The library of your friends and communities

You are offline